Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1131-1140 of 1,367) with videos related to

Pageof 137
Sort By:
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
The Journal of Infectious Diseases|August 27, 2002
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccinationMartin Markowitz, Xia Jin, Arlene Hurley, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Cell Reports|October 15, 2025
Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariantsIan A Mellis, Madeline Wu, Hsiang Hong, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Plos One|May 30, 2013
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletionMarkus Munder, Melanie Engelhardt, Diana Knies, et al.
Journal of Virology|November 13, 1998
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)F Gao, D L Robertson, C D Carruthers, et al.
Journal of Virology|February 15, 2005
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding regionZhiwei Chen, Linqi Zhang, Chuan Qin, et al.
Frontiers in Genetics|December 19, 2017
Analysis of the Expression of Repetitive DNA Elements in OsteosarcomaXuan D Ho, Hoang G Nguyen, Le H Trinh, et al.
Cytotherapy|June 4, 2002
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantationA Bashey, S Corringham, E Gilpin, et al.
Pageof 137

Showing results (1131-1140 of 1,367) with videos related to

Sort By:
Pageof 137
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
The Journal of Infectious Diseases|August 27, 2002
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccinationMartin Markowitz, Xia Jin, Arlene Hurley, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Cell Reports|October 15, 2025
Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariantsIan A Mellis, Madeline Wu, Hsiang Hong, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Plos One|May 30, 2013
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletionMarkus Munder, Melanie Engelhardt, Diana Knies, et al.
Journal of Virology|November 13, 1998
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)F Gao, D L Robertson, C D Carruthers, et al.
Journal of Virology|February 15, 2005
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding regionZhiwei Chen, Linqi Zhang, Chuan Qin, et al.
Frontiers in Genetics|December 19, 2017
Analysis of the Expression of Repetitive DNA Elements in OsteosarcomaXuan D Ho, Hoang G Nguyen, Le H Trinh, et al.
Cytotherapy|June 4, 2002
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantationA Bashey, S Corringham, E Gilpin, et al.
Pageof 137